• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148

Introduction to 2-Amino-N-(2-phenylethyl)benzamide (CAS No. 19050-62-5) and Its Emerging Applications in Chemical Biology

The compound 2-Amino-N-(2-phenylethyl)benzamide (CAS No. 19050-62-5) represents a fascinating molecule in the realm of chemical biology, characterized by its unique structural framework and promising biological activities. This amide derivative, featuring a benzamide core linked to an N-(2-phenylethyl) group, has garnered significant attention due to its potential therapeutic applications and mechanistic insights into biological pathways. The structural motif of this compound not only underscores its versatility but also highlights its relevance in contemporary drug discovery efforts.

Recent advancements in the field of medicinal chemistry have positioned 2-Amino-N-(2-phenylethyl)benzamide as a valuable scaffold for developing novel bioactive molecules. The benzamide moiety, a well-documented pharmacophore, is known for its role in modulating various enzymatic and receptor interactions. In particular, the N-(2-phenylethyl) substituent introduces steric and electronic properties that can fine-tune the compound's binding affinity and selectivity. This dual functionality has made it an attractive candidate for investigating interactions with biological targets such as kinases, proteases, and transcription factors.

One of the most compelling aspects of 2-Amino-N-(2-phenylethyl)benzamide is its potential in addressing unmet medical needs. Emerging research suggests that this compound exhibits inhibitory effects on certain enzymes implicated in inflammatory and oncogenic pathways. For instance, studies have demonstrated its ability to modulate the activity of cyclooxygenase (COX) enzymes, which are pivotal in the production of prostaglandins mediating inflammation. Furthermore, preliminary data indicate that derivatives of this scaffold may interact with Janus kinases (JAKs), a family of enzymes central to immune signaling cascades.

The structural diversity inherent in 2-Amino-N-(2-phenylethyl)benzamide also opens avenues for exploring its role in neurobiology. The phenethylamine moiety, reminiscent of classical psychoactive compounds, hints at potential interactions with neurotransmitter systems. While direct evidence is still emerging, the compound's ability to cross the blood-brain barrier makes it a candidate for investigating neuroinflammatory conditions and neurodegenerative disorders. The benzamide group further supports its candidacy as a modulator of neuronal signaling pathways, particularly those involving glutamate receptors and GABAergic systems.

In the context of drug development pipelines, 2-Amino-N-(2-phenylethyl)benzamide exemplifies the importance of structural optimization in enhancing pharmacological properties. Computational modeling and high-throughput screening have been instrumental in identifying analogs with improved solubility, metabolic stability, and target engagement. These efforts align with global trends toward rational drug design, where computational tools are leveraged to predict molecular interactions and optimize lead compounds.

The synthesis of 2-Amino-N-(2-phenylethyl)benzamide itself is another area where modern chemical methodologies have made significant strides. Advances in peptide coupling techniques and transition-metal-catalyzed reactions have streamlined the preparation of complex amide derivatives like this one. Such innovations not only improve yield but also enable the introduction of diverse functional groups, expanding the chemical space available for drug discovery.

From a regulatory perspective, CAS No. 19050-62-5 provides a unique identifier that ensures consistency across scientific literature and patent filings. This standardized nomenclature is crucial for reproducibility in research and for facilitating collaborations between academic institutions and pharmaceutical companies. The availability of reference materials under this CAS number further underscores the compound's significance in industrial-scale synthesis and quality control processes.

The future prospects for 2-Amino-N-(2-phenylethyl)benzamide are bright, particularly as interdisciplinary approaches continue to bridge gaps between chemistry, biology, and medicine. Ongoing studies are expected to uncover novel mechanisms of action and expand its therapeutic potential beyond initial hypotheses. Collaborative efforts between synthetic chemists and biochemists will be essential in translating laboratory findings into clinical applications.

In conclusion, 2-Amino-N-(2-phenylethyl)benzamide stands as a testament to the innovative spirit driving modern chemical biology research. Its unique structure offers multiple avenues for exploration, from modulating inflammatory responses to addressing neurobiological disorders. As our understanding of biological systems evolves, CAS No 19050 -62 -5 will undoubtedly play a pivotal role in shaping future therapeutic strategies.

• 5471-20-5(2-Amino-N-benzylbenzamide)
• 10494-82-3(2-Amino-N-butylbenzamide)
• 32212-29-6(2-Amino-N-Ethylbenzamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)